Publications by authors named "Daniel Hendler"

Claim this Profile
C
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation.
Itamar Averbuch, Nofar Edri, Nethanel Asher, Gal Markel, Daniel Hendler

Cancer Immunol Immunother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.
Itamar Averbuch, Saeed Salman, Noa Shtamper, Ilana Doweck, Aron Popovtzer, Daniel Hendler

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101).
Hani Babiker, Erkut Borazanci, Vivek Subbiah, Sanjiv Agarwala, Alain Algazi, Daniel Hendler

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.
Daniel Reinhorn, Iryna Kuchuk, Tzippy Shochat, Bella Nisenbaum, Aaron Sulkes, Daniel Hendler

Breast Cancer Res Treat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
Matan Ben-Zion Berliner, Rinat Yerushalmi, Inbar Lavie, Alexandra Benouaich-Amiel, Daliah Tsoref, Daniel Hendler

Breast Cancer Res Treat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer.
Yosef Landman, Salomon Marcello Stemmer, Aaron Sulkes, Victoria Neiman, Tal Granot, Daniel Hendler

J Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between smoking and breast cancer characteristics and outcome.
Hadar Goldvaser, Omer Gal, Shulamith Rizel, Daniel Hendler, Victoria Neiman

BMC Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics.
Hadar Goldvaser, Shulamit Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich

Oncology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics.
Hadar Goldvaser, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich

Int J Endocrinol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinic.
Ayelet Ollech, Salomon M Stemmer, Sharon Merims, Michal Lotem, Aron Popovtzer, Daniel Hendler

Int J Dermatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis.
Rinat Yerushalmi, Hadar Goldvaser, Aaron Sulkes, Irit Ben-Aharon, Daniel Hendler

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring neoadjuvant chemotherapy for locally advanced breast cancer: a historical prospective study.
Alona Zer, Shulamit Rizel, Rony Braunstein, Rinat Yerushalmi, Daniel Hendler

Chemotherapy· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different schedules of granulocyte growth factor support for patients with breast cancer receiving adjuvant dose-dense chemotherapy: a prospective nonrandomized study.
Daniel Hendler, Shulamith Rizel, Rinat Yerushalmi, Victoria Neiman, Luisa Bonilla

Am J Clin Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon reason for high fluorodeoxyglucose positron emission tomography uptake.
Daniel Hendler, Salomon M Stemmer

J Clin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis